Pharmazon has received a minority investment from a private investor

The shareholders of Pharmazon have sold the company to a private investor.

Pharmazon is a B2B distributor of OTC and parapharmacy products to French pharmacies. Its core business is to buy products directly from laboratories, negotiating good conditions and selling them online through a modern website which looks similar to Amazon.com.

The company's shareholders are the CEO and General Director.

Oaklins' team in France advised the seller in this transaction.

Service

M&A sell-side

Parties

Talk to the deal team

Ludovic Beaulieu

Partner

Paris, France
Oaklins France

View profile Get in touch

Antoine Lemaire

Partner

Paris, France
Oaklins France

View profile Get in touch

Related deals

Ace Pharmaceuticals has been acquired by Gilde Buy Out Partners, Gilde Healthcare and Quadrum Capital

Private Equity | Healthcare

Ace Pharmaceuticals has been acquired by Gilde Buy Out Partners, Gilde Healthcare and Quadrum Capital

Ace Pharmaceuticals BV has been acquired by Gilde Buy Out Partners, Gilde Healthcare, Quadrum Capital and the management team.

Learn more

Renita Medical raises seed funding

Healthcare | TMT

Renita Medical raises seed funding

Renita Medical Oy, a health tech company, has received seed funding which provides it with resources to finalize development and bring it to commercial launch.

Learn more

Bionix has been recapitalized by Argosy Private Equity

Private Equity | Healthcare

Bionix has been recapitalized by Argosy Private Equity

Bionix, LLC has been recapitalized by Argosy Private Equity.

Learn more